Medtronic Aktie
WKN DE: A14M2J / ISIN: IE00BTN1Y115
10.06.2019 14:30:06
|
Medtronic Announces Its Forthcoming Robotic Assisted Surgical Platform to Feature Three-Dimensional Vision System from KARL STORZ
Four Year Partnership Made Public Today
DUBLIN - June 10, 2019 - To enable upcoming regulatory filings, Medtronic plc (NYSE:MDT) today made public its partnership with KARL STORZ SE & Co. KG (Tuttlingen, Germany), a pioneer in the field of endoscopic imaging. For the past four years, the two companies have partnered to seamlessly integrate KARL STORZ'S three-dimensional (3D) vision systems and visualization components into Medtronic's forthcoming robotic assisted surgical platform.
"Visualization is critical to the successful execution of robotic assisted surgeries and minimally invasive surgeries," said Megan Rosengarten, vice president and general manager of the Surgical Robotics business, which is part of the Minimally Invasive Therapies Group at Medtronic. "As we developed our robotic platform, we led with surgeons' input to design a flexible surgical system that meets their needs and the needs of patients around the globe. Surgeons can be confident our robotic assisted platform will provide market leading 3D visualization technology combined with best in-class surgical stapling and energy instruments."
Visualization Technology Leadership
KARL STORZ is a pioneer in the field of endoscopic imaging, recognized for industry-first visualization innovations, such as the FULL HD endoscopic camera. Today, Medtronic and KARL STORZ are leveraging the latest generation of IMAGE1 S(TM) 3D platform to deliver outstanding image quality and depth perception to surgeons.
About KARL STORZ
KARL STORZ SE & Co. KG (Tuttlingen, Germany) has grown over the last seven decades into a globally active player with 8,000 employees that stands for innovative excellence in endoscopy and visualization technology. Throughout its history, the company has focused on supplying functional and ergonomic products to meet medical needs as well as using technology for the benefit of patients.
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services, and solutions companies - alleviating pain, restoring health, and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals, and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
-end-
Contacts:
John Jordan
Public Relations
+1-508-452-4891
Ryan Weispfenning
Investor Relations
+1-763-505-4626
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Medtronic plc via Globenewswire

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Medtronic PLCmehr Nachrichten
27.03.25 |
S&P 500-Wert Medtronic-Aktie: So viel hätte eine Investition in Medtronic von vor einem Jahr abgeworfen (finanzen.at) | |
20.03.25 |
S&P 500-Papier Medtronic-Aktie: So viel Gewinn hätte ein Medtronic-Investment von vor 10 Jahren abgeworfen (finanzen.at) | |
13.03.25 |
S&P 500-Titel Medtronic-Aktie: So viel hätte eine Investition in Medtronic von vor 5 Jahren abgeworfen (finanzen.at) | |
06.03.25 |
S&P 500-Wert Medtronic-Aktie: So viel hätten Anleger mit einem Investment in Medtronic von vor 3 Jahren verloren (finanzen.at) | |
27.02.25 |
S&P 500-Wert Medtronic-Aktie: So viel Gewinn hätte ein Investment in Medtronic von vor einem Jahr eingebracht (finanzen.at) | |
20.02.25 |
S&P 500-Wert Medtronic-Aktie: So viel Gewinn hätte ein Investment in Medtronic von vor 10 Jahren eingebracht (finanzen.at) | |
18.02.25 |
Optimismus in New York: S&P 500 zum Ende des Dienstagshandels im Plus (finanzen.at) | |
18.02.25 |
Zurückhaltung in New York: S&P 500 sackt nachmittags ab (finanzen.at) |
Analysen zu Medtronic PLCmehr Analysen
Aktien in diesem Artikel
Medtronic PLC | 83,07 | 2,35% |
|